Investors / United States / ABio-X
ABio-X
Investor · Needham, MA, United States · North America
ABio-X is a life sciences incubation platform that creates and invests in biotech companies, providing R&D and G&A functions to its member companies. It was founded in 2021 with $300M backed by CBC Group and is headquartered in the Boston area.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechincubationtherapeuticsdrug development
Your fit with ABio-X
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsABio-X lists 3 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Eight Roads, F-Prime Capital and Mitsui Global Investment.
No funding round on record names ABio-X yet, so the figures come from its portfolio page.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Eight Roads | 1 |
| F-Prime Capital | 1 |
| Mitsui Global Investment | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare ABio-X head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its sitePortfolio
3 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adcentrx Therapeutics is a clinical-stage biotechnology company focused on accelerating breakthroughs in developing protein conjugate therapeutics for cancer and other life-threatening diseases. | Healthcare & Biotech | Portfolio page | ||
| Ensem Therapeutics develops innovative small molecule precision medicines for oncology using its Kinetic Ensemble platform | Healthcare & Biotech | Portfolio page | ||
| MLAB Biosciences is a biotechnology company that leverages its proprietary DIRECT platform to discover and develop novel antibody-based therapies for muscular dystrophies and other unmet medical needs. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- abio-x.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 3
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get ABio-X's profile as data
Pull ABio-X's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/abio-x.com
# also
GET /v1/firms/abio-x.com/portfolio
GET /v1/firms/abio-x.com/coinvestors
GET /v1/firms/abio-x.com/news